| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385864A1 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385856A2 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| 02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
| 02/04/2004 | EP1385843A1 Arylindenopyridines with pde inhibiting activity |
| 02/04/2004 | EP1385841A1 Sulfonamides |
| 02/04/2004 | EP1385840A1 Sulfonamides |
| 02/04/2004 | EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385578A1 Utilization of rutins and aescins in the treatment of circulatory disturbances of the ear |
| 02/04/2004 | EP1385550A2 Therapeutic method for inducing tolerance |
| 02/04/2004 | EP1385528A2 Disinfecting and solubilizing steroid compositions |
| 02/04/2004 | EP1385526A2 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | EP1385518A1 Benzimidazolone compounds |
| 02/04/2004 | EP1385514A1 Spiroindene and spiroindane compounds |
| 02/04/2004 | EP1385508A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/04/2004 | EP1385507A1 Sulfonamides |
| 02/04/2004 | EP1385496A2 Use of compositions for treating rosacea |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1385476A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 02/04/2004 | EP1267847B1 5ht 2 agonists for controlling iop and treating glaucoma |
| 02/04/2004 | EP1237549B1 Lipoxin a4 and analogues for the treatment of dry eye |
| 02/04/2004 | EP1185291B1 Therapeutic agent comprising a botulinum neurotoxin |
| 02/04/2004 | CN1473148A Novel crystals of N-hydroxy-2(S)-methyl-5-ethoxymethoxy-4(S)-[N-(4- phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing crystals as active ingredient |
| 02/04/2004 | CN1473050A Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 02/04/2004 | CN1473047A Method for treating hypogonadism |
| 02/04/2004 | CN1473046A Improved treatment |
| 02/04/2004 | CN1473039A Remedies for heratoconjunctival diseases containing farnesyl acetate as the active ingredient |
| 02/04/2004 | CN1471969A Medicinal use of recombined human interleukin-1 receptor antagonist |
| 02/04/2004 | CN1471943A Eyesight healthy oral liquid |
| 02/04/2004 | CN1471924A Medicinal liquid for resuming presbyopia eyesight |
| 02/04/2004 | CN1471917A Western medicine vitamin mixture for Meniere's disease |
| 02/04/2004 | CN1471910A Preparing method for suspensoid of complete trans vitamin A acid |
| 02/04/2004 | CN1136906C Medicine for preventing and treating myopia and amlyopia |
| 02/04/2004 | CN1136854C Se-contained cyclodextrin and its application in preparing medicine to treat cataract |
| 02/03/2004 | US6686384 2-anilinophenyl-substituted; inhibition of the na+/h+ exchanger |
| 02/03/2004 | US6686382 N-(isoxazolyl)thienylsulfonamides, n-(isoxazolyl)furylsulfonamides, n-(isoxazolyl)pyrrolylsulfonamides and n-(isoxazolyl)phenylsulfonamides; inhibit endothelin |
| 02/03/2004 | US6686373 Analgesics; antiinflammatory agent |
| 02/03/2004 | US6686351 Compounds and methods for modulation of estrogen receptors |
| 02/03/2004 | US6686347 Phthalazine derivatives for treating inflammatory diseases |
| 02/03/2004 | US6686335 Hydroxamate-containing cysteine and serine protease inhibitors |
| 02/03/2004 | US6686148 Methods for targeting RNA molecules |
| 02/03/2004 | US6685950 Methods of treating viral infections |
| 02/03/2004 | US6685934 Neurodegenerative diseases. |
| 02/03/2004 | US6685917 Treatment of mucositis |
| 02/03/2004 | CA2300806C Dexamethasone gel |
| 01/31/2004 | CA2436469A1 Composition for heart disease, method to prepare same and uses thereof |
| 01/29/2004 | WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |
| 01/29/2004 | WO2004009588A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 01/29/2004 | WO2004009582A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | WO2004009579A1 Novel compounds |
| 01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | WO2004009555A1 5-substituted isoquinoline derivative |
| 01/29/2004 | WO2004009547A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009546A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009537A1 NOVEL α-KETOAMIDE DERIVATIVE AND USE THEREOF |
| 01/29/2004 | WO2004009528A1 2,4-dihydroxybenzoic acid derivatives |
| 01/29/2004 | WO2004009521A1 Remedy |
| 01/29/2004 | WO2004009113A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 01/29/2004 | WO2004009111A1 Corneal epithelium injury-healing accelerator |
| 01/29/2004 | WO2004009099A1 Phosphorylated dextran |
| 01/29/2004 | WO2004009072A2 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 01/29/2004 | WO2004009062A2 NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau |
| 01/29/2004 | WO2004009056A1 Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent |
| 01/29/2004 | WO2004009030A2 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/29/2004 | WO2003087357A3 Nucleic acid comprising retinal-specific regulatory region |
| 01/29/2004 | WO2003065980A3 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 01/29/2004 | WO2003053923A3 Pyrrolidine derivatives as prostaglandin modulators |
| 01/29/2004 | WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 01/29/2004 | WO2003040080A3 Lipoxin a4 analogs |
| 01/29/2004 | WO2003020324A3 Methods for sterilizing preparations of digestive enzymes |
| 01/29/2004 | WO2003000194A3 Thienopyridine and thienopyrimidine anticancer agents |
| 01/29/2004 | WO2003000180A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | US20040019210 Kinase inhibitors |
| 01/29/2004 | US20040019208 5-Aryltetrazole Compounds, compositions thereof, and uses therefor |
| 01/29/2004 | US20040019118 Therapeutic treatment with a 1-aminocyclohexane derivatives or 1-aminoadamantane compounds, such as mamantine or neramexane; new use of existing drug |
| 01/29/2004 | US20040019114 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical |
| 01/29/2004 | US20040019111 A new use of existing pharmaceutical, a nonsteroidal antiinflammatory agents |
| 01/29/2004 | US20040019099 Treating inflammatory diseases, allergic conditions and central nervous system disorders |
| 01/29/2004 | US20040019072 Dimer-selective RXR modulators and methods for their use |
| 01/29/2004 | US20040019060 Drugs such as 9-(3,5-dimethyl-1-piperazinyl)propyl)carbazole, used for modulating endothelial cell proliferation |
| 01/29/2004 | US20040019048 Imidazo(4,5-c)quinoline and the 6,7,8,9-tetrahydro derivative having urea, thiourea, acylurea or sulfonylurea at the 1-position as immune response modifiers; biosynthesis of cytokines; viricides; antitumor, -carcinogenic agents |
| 01/29/2004 | US20040019045 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/29/2004 | US20040019037 E.g.,((5-(2,4-Diaminopyrimidin-6-yl)pentanoyl)-(N-methyl)amino )-3-(6-meth-oxypyridin-3-yl)-propanoic acid, inhibition of bone resorption, restenosis, angiogenesis inhibitors, antiarthritic, -tumor, -carcinogenic agents; antidiabetic |
| 01/29/2004 | US20040019034 Pyrrolotriazolopyrimidinone derivatives |
| 01/29/2004 | US20040019032 Photodynamic therapy to treat for retinal macular edema (ME) that's more effective and less damaging to tissue surrounding an edematous lesion than laser photocoagulation; ME resulting from diabetes or central or branch retinal vein occulsion |
| 01/29/2004 | US20040019015 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss |
| 01/29/2004 | US20040019012 A therapeutic drug suitable for topical administration to an eye, containing an antibiotic for gram-positive bacterial infection, a cyclodextrin compound to maintain drug in solution and cetylpyridium chloride |
| 01/29/2004 | US20040018972 Autoimmune diseases; antiallergens; rheumatic diseases; antiinflammatory agents |
| 01/29/2004 | DE10229778A1 Neue Verwendung von Imidazotriazinonen New use of imidazotriazinones |
| 01/29/2004 | DE10229180A1 Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen Use of vasopeptidase inhibitors for the treatment of metabolic disorders, nephropathy, and diseases associated with AGE |
| 01/29/2004 | CA2493774A1 2,4-dihydroxybenzoic acid derivatives |
| 01/29/2004 | CA2493721A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | CA2493544A1 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |